Orthofix Medical (OFIX) Other Accumulated Expenses (2010 - 2026)

Orthofix Medical (OFIX) has 17 years of Other Accumulated Expenses data on file, last reported at $106.2 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 8.21% year-over-year to $106.2 million; the trailing twelve-month figure through Mar 2026 stood at $106.2 million (up 8.21% YoY), and the FY2025 full-year result was $111.3 million, down 6.57% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $106.2 million, down from $111.3 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $119.1 million in Q4 2024 and bottomed at $48.2 million in Q2 2022.
• A 5-year average of $90.6 million and a median of $98.6 million in 2023 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses declined 27.88% in 2022 and soared 101.15% in 2023, its largest moves.
• Tracing OFIX's Other Accumulated Expenses over 5 years: stood at $55.4 million in 2022, then surged by 89.45% to $104.9 million in 2023, then rose by 13.5% to $119.1 million in 2024, then slipped by 6.57% to $111.3 million in 2025, then decreased by 4.51% to $106.2 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $106.2 million, $111.3 million, and $108.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison